| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.33B | 36.29B | 30.45B | 35.38B | 37.30B | 32.89B |
| Gross Profit | 8.62B | 8.26B | 6.45B | 7.41B | 8.90B | 8.21B |
| EBITDA | 7.23B | 7.07B | 5.41B | 5.99B | 9.59B | 7.04B |
| Net Income | 2.90B | 2.89B | 1.84B | 2.28B | 5.36B | 2.96B |
Balance Sheet | ||||||
| Total Assets | 58.99B | 60.73B | 58.62B | 55.47B | 56.60B | 52.93B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 16.64B | 16.23B | 15.10B | 15.89B | 15.57B |
| Total Debt | 5.58B | 5.37B | 4.93B | 3.92B | 5.42B | 8.71B |
| Total Liabilities | 14.58B | 15.73B | 14.12B | 12.31B | 13.87B | 16.18B |
| Stockholders Equity | 44.18B | 44.75B | 44.26B | 42.92B | 42.22B | 36.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.95B | 683.00M | 1.05B | 2.68B | 4.92B |
| Operating Cash Flow | 0.00 | 7.12B | 6.54B | 5.63B | 5.40B | 7.35B |
| Investing Cash Flow | 0.00 | -4.32B | -5.83B | -3.28B | -5.67B | -2.46B |
| Financing Cash Flow | 0.00 | -2.83B | -141.00M | -3.72B | 94.00M | -3.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥86.73B | 11.63 | 10.57% | 1.74% | 15.12% | 40.72% | |
77 Outperform | ¥63.55B | 13.90 | ― | 2.92% | 3.03% | 28.27% | |
72 Outperform | ¥57.59B | 18.60 | 6.31% | 4.01% | 6.38% | 22.81% | |
70 Outperform | ¥55.03B | 8.46 | ― | 4.37% | -1.09% | ― | |
67 Neutral | ¥56.60B | 12.57 | ― | 2.81% | 8.28% | 0.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥66.81B | 34.78 | ― | 1.60% | 1.20% | ― |
Stella Chemifa Corporation announced an update to its management strategy, emphasizing a focus on capital cost and stock price management. This decision reflects the company’s ongoing analysis and evaluation of its current situation and the progress of its initiatives, potentially impacting its operational efficiency and market positioning.
The most recent analyst rating on (JP:4109) stock is a Buy with a Yen4607.00 price target. To see the full list of analyst forecasts on Stella Chemifa stock, see the JP:4109 Stock Forecast page.
Stella Chemifa Corporation reported its consolidated financial results for the six months ended September 30, 2025, showing stable sales revenue but notable increases in operating and ordinary profit compared to the previous year. Despite a slight decrease in comprehensive income, the company maintained a strong equity-to-asset ratio, indicating financial stability. The forecast for the fiscal year ending March 31, 2026, anticipates a slight decline in sales and profits, reflecting cautious market conditions.
The most recent analyst rating on (JP:4109) stock is a Buy with a Yen4607.00 price target. To see the full list of analyst forecasts on Stella Chemifa stock, see the JP:4109 Stock Forecast page.
Stella Chemifa Corporation has announced an interim dividend of ¥85.00 per share for the fiscal year ending March 31, 2026, as resolved by its Board of Directors. This decision aligns with the company’s policy to maintain stable dividends while aiming for a total return ratio of 100% or more over the three-year period from FYE 2026 to FYE 2028, balancing growth investments with shareholder returns.
The most recent analyst rating on (JP:4109) stock is a Buy with a Yen4607.00 price target. To see the full list of analyst forecasts on Stella Chemifa stock, see the JP:4109 Stock Forecast page.